Evidence map›Paper›PMID 37752220›Full record

ArticleScientific reports2023

Recovery of the histamine H

Ayami Watanabe, Ami Nakajima, Mitsunori Shiroishi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Activity-restoring mutations in the histamine HProtein science : a publication of the Protein Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ayami Watanabe *Department of Biological Science and Technology, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.
Ami Nakajima *Department of Biological Science and Technology, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.
Mitsunori ShiroishiDepartment of Biological Science and Technology, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan. shiroishi@rs.tus.ac.jp.
Tokyo University of Science · JP

Funding

Japan Agency for Medical Research and Development Platform Project for Supporting in Drug Discovery and Life Science ResearchJapan Society for the Promotion of Science JP25709080Ministry of Education, Culture, Sports, Science and Technology Platform Project for Supporting in Drug Discovery and Life Science Research
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are the largest protein family in humans and are important drug targets. Yeast, especially Saccharomyces cerevisiae, is a useful host for modifying the function and stability of GPCRs through protein engineering, which is advantageous for mammalian cells. When GPCRs are expressed in yeast, their function is often impaired. In this study, we performed random mutagenesis using error-prone PCR and then an in vivo screening to obtain mutants that recovered the activity of the human histamine H

Indexed as

Receptors, Histamine H3Saccharomyces cerevisiaeAnimalsHistamineHumansMammalsPolymerase Chain ReactionReceptors, G-Protein-CoupledReceptors, HistamineRecombinant ProteinsSignal TransductionHistamineReceptors, G-Protein-CoupledReceptors, HistamineReceptors, Histamine H3Recombinant Proteins

Identifiers

PMID37752220
PMCPMC10522717
OpenAlexW4387060533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.